174 related articles for article (PubMed ID: 37602889)
1. Study protocol: A comparison of mobile and clinic-based spirometry for capturing the treatment effect in moderate asthma.
Izmailova ES; Kilian R; Bakker JP; Evans S; Scotina AD; Reiss TF; Singh D; Wagner JA
Clin Transl Sci; 2023 Nov; 16(11):2112-2122. PubMed ID: 37602889
[TBL] [Abstract][Full Text] [Related]
2. Remote FEV1 Monitoring in Asthma Patients: A Pilot Study.
Huang C; Izmailova ES; Jackson N; Ellis R; Bhatia G; Ruddy M; Singh D
Clin Transl Sci; 2021 Mar; 14(2):529-535. PubMed ID: 33048470
[TBL] [Abstract][Full Text] [Related]
3. Anticholinergic vs Long-Acting β-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma: The BELT Randomized Clinical Trial.
Wechsler ME; Yawn BP; Fuhlbrigge AL; Pace WD; Pencina MJ; Doros G; Kazani S; Raby BA; Lanzillotti J; Madison S; Israel E;
JAMA; 2015 Oct; 314(16):1720-30. PubMed ID: 26505596
[TBL] [Abstract][Full Text] [Related]
4. Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma.
Kew KM; Dahri K
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011721. PubMed ID: 26798035
[TBL] [Abstract][Full Text] [Related]
5. Relationship between handheld and clinic-based spirometry measurements in asthma patients receiving beclomethasone.
Kerwin EM; Hickey L; Small CJ
Respir Med; 2019 May; 151():35-42. PubMed ID: 31047115
[TBL] [Abstract][Full Text] [Related]
6. Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma.
Crossingham I; Turner S; Ramakrishnan S; Fries A; Gowell M; Yasmin F; Richardson R; Webb P; O'Boyle E; Hinks TS
Cochrane Database Syst Rev; 2021 May; 5(5):CD013518. PubMed ID: 33945639
[TBL] [Abstract][Full Text] [Related]
7. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
[TBL] [Abstract][Full Text] [Related]
8. Clinic vs Home Spirometry for Monitoring Lung Function in Patients With Asthma.
Oppenheimer J; Hanania NA; Chaudhuri R; Sagara H; Bailes Z; Fowler A; Peachey G; Pizzichini E; Slade D
Chest; 2023 Nov; 164(5):1087-1096. PubMed ID: 37385337
[TBL] [Abstract][Full Text] [Related]
9. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2-agonists (LABA) for adults with asthma.
Kew KM; Evans DJ; Allison DE; Boyter AC
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011438. PubMed ID: 26031392
[TBL] [Abstract][Full Text] [Related]
10. Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD).
Horita N; Goto A; Shibata Y; Ota E; Nakashima K; Nagai K; Kaneko T
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD012066. PubMed ID: 28185242
[TBL] [Abstract][Full Text] [Related]
11. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H
Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial.
Donohue JF; Wise R; Busse WW; Garfinkel S; Zubek VB; Ghafouri M; Manuel RC; Schlenker-Herceg R; Bleecker ER
BMC Pulm Med; 2016 Apr; 16(1):65. PubMed ID: 27130202
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome.
Lee SY; Park HY; Kim EK; Lim SY; Rhee CK; Hwang YI; Oh YM; Lee SD; Park YB
Int J Chron Obstruct Pulmon Dis; 2016; 11():2797-2803. PubMed ID: 27877033
[TBL] [Abstract][Full Text] [Related]
14. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease.
Farne HA; Cates CJ
Cochrane Database Syst Rev; 2015 Oct; (10):CD008989. PubMed ID: 26490945
[TBL] [Abstract][Full Text] [Related]
15. Abediterol (LAS100977), a novel long-acting β2-agonist: efficacy, safety and tolerability in persistent asthma.
Beier J; Fuhr R; Massana E; Jiménez E; Seoane B; de Miquel G; Ruiz S
Respir Med; 2014 Oct; 108(10):1424-9. PubMed ID: 25256258
[TBL] [Abstract][Full Text] [Related]
16. Effects of formoterol or salmeterol on impulse oscillometry in patients with persistent asthma.
Manoharan A; von Wilamowitz-Moellendorff A; Morrison A; Lipworth BJ
J Allergy Clin Immunol; 2016 Mar; 137(3):727-33.e1. PubMed ID: 26220533
[TBL] [Abstract][Full Text] [Related]
17. Assessment of spirometry and impulse oscillometry in relation to asthma control.
Manoharan A; Anderson WJ; Lipworth J; Lipworth BJ
Lung; 2015 Feb; 193(1):47-51. PubMed ID: 25516285
[TBL] [Abstract][Full Text] [Related]
18. Combined inhaled beta-agonist and anticholinergic agents for emergency management in adults with asthma.
Kirkland SW; Vandenberghe C; Voaklander B; Nikel T; Campbell S; Rowe BH
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD001284. PubMed ID: 28076656
[TBL] [Abstract][Full Text] [Related]
19. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.
Chauhan BF; Ducharme FM
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003137. PubMed ID: 24459050
[TBL] [Abstract][Full Text] [Related]
20. Long-acting beta2-agonists for chronic obstructive pulmonary disease.
Kew KM; Mavergames C; Walters JA
Cochrane Database Syst Rev; 2013 Oct; (10):CD010177. PubMed ID: 24127118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
